Angco, Baby Boy .
HRN: 29-12-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/05/2026
06/12/2026
IV
50mg
Q24H
T/C MAS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes